Progressive states of cell-cycle withdrawal
细胞周期退出的进行性状态
基本信息
- 批准号:10803979
- 负责人:
- 金额:$ 34.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-30 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AgeAgingAlgorithmsBiological MarkersBiologyCell AgingCell Culture TechniquesCell CycleCell Cycle ProgressionCell SeparationCell divisionCell physiologyCellsChronic DiseaseChronologyDNA DamageDevelopmentDiseaseDrug usageEventFlow CytometryFunctional disorderGenotoxic StressHealth Care CostsHumanKnowledgeLengthLightMalignant NeoplasmsMeasuresMedicalMicroscopyModelingModernizationMolecularMorbidity - disease rateNaturePathologyPharmaceutical PreparationsPhysiologicalPopulationProbabilityProcessProliferatingRegenerative capacityRejuvenationRelapseRestRoleSafetySomatic CellSortingTechnologyTestingTherapeuticWithdrawalWorkcancer therapycell agecell injurychemotherapeutic agentgenetic signaturegenotoxicityhuman diseasehuman old age (65+)improvedinflammatory milieumolecular markermortalitypredictive signaturepreventreproductivesenescencesensorsingle cell technologysingle-cell RNA sequencingtelomeretranscriptomicstumor
项目摘要
Project Summary
Senescence is the process by which a cell permanently stops proliferating due to cellular aging
or damage but does not die. Induction of senescence is often desirable during cancer treatment
to prevent the proliferation of aberrant cells, but it also impedes cellular function and
regenerative capacity as we age. The study of cellular senescence is hindered by the fact that
senescence is difficult to distinguish from other states of cell-cycle withdrawal such as
quiescence, a transient cellular resting state. This is because quiescence and senescence are
defined by overlapping molecular markers and because these cell-cycle transitions occur
heterogeneously from cell to cell. Despite obvious medical relevance, it is unclear whether
senescence and quiescence are truly distinct states. Here we propose to test the hypothesis
that senescence and quiescence exist on a continuum of cell-cycle withdrawal where the
probability of cell-cycle re-entry steadily declines toward zero as cells become senescent.
We will leverage our unique expertise in long-term, time-lapse microscopy, automated single-
cell tracking, and the development of sensors for cell-cycle progression and cell-cycle
withdrawal to unveil gradations of cell-cycle withdrawal that are invisible by standard bulk
approaches. Our specific aims are 1) To determine the predictive power of prevailing
senescence markers as binary markers of senescence and as graded markers of quiescence
depth, 2) To determine at the transcriptomic level whether quiescence and senescence are
distinct states or part of a continuum of cell-cycle withdrawal, and 3) To the identify the DNA
damage and telomere features that predict permanent cell-cycle withdrawal as cells age toward
replicative senescence.
If successful, this work will improve our ability to define molecularly the state of senescence and
will generate new fundamental knowledge about the onset of senescence. Our work could
improve the ability to predict tumor relapse after cancer therapy, help quantify a cell’s
physiological age and reproductive potential, identify ways to rejuvenate aged cells, and
improve the safety of senolytic drugs that eliminate senescent cells.
项目摘要
衰老是由于细胞衰老而永久停止增殖的过程
或损坏但不会死亡。癌症治疗期间通常需要诱导感应
为了防止异常细胞的扩散,但也阻碍了细胞功能和
随着年龄的增长,再生能力。细胞感应的研究受到了以下事实的阻碍
感应很难与其他细胞周期戒断状态区分开,例如
静止,瞬态细胞静止状态。这是因为静态和感受是
由重叠的分子标记定义,并且因为这些细胞周期过渡发生
从细胞到细胞异质。尽管有明显的医学相关性,但尚不清楚是否存在
感应和静止是真正不同的状态。在这里,我们建议检验假设
这种敏感和静止存在于细胞周期戒断的连续元素上
随着细胞的感觉,细胞周期重新进入的概率稳步下降向零。
我们将利用我们在长期,延时显微镜下的独特专业知识,自动化的单个
细胞跟踪,以及用于细胞周期进展和细胞周期的传感器的发展
提取到标准散装看不见的细胞周期提取的级别
方法。我们的具体目标是1)确定流行的预测能力
感应标记作为感应的二元标记和静态标记
深度,2)在转录组水平上确定静止和感应是否为
细胞周期戒断连续的不同状态或一部分,3)识别DNA
随着细胞的衰老而预测永久性细胞周期戒断的损伤和端粒特征
复制感应。
如果成功,这项工作将提高我们定义分子感应状态的能力和
将产生有关感应发作的新基本知识。我们的工作可以
提高癌症治疗后预测肿瘤缓解的能力,有助于量化细胞
实物时代和生殖潜力,确定恢复老化细胞的方法,以及
改善消除感觉细胞的鼻溶剂的安全性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sabrina Leigh Spencer其他文献
Sabrina Leigh Spencer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sabrina Leigh Spencer', 18)}}的其他基金
Proliferation-quiescence control by integration of stress and mitogen signaling
通过整合应激和有丝分裂原信号传导来控制增殖-静止
- 批准号:
8766464 - 财政年份:2014
- 资助金额:
$ 34.96万 - 项目类别:
相似国自然基金
FOXO3 m6A甲基化修饰诱导滋养细胞衰老效应在补肾法治疗自然流产中的机制研究
- 批准号:82305286
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于巨噬细胞表型转变探讨BTSA1诱导衰老肌成纤维细胞凋亡及促肺纤维化消退的机制
- 批准号:82370077
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
仙茅酚苷类成分靶向组蛋白去乙酰化酶HDAC1抑制BMSC衰老防治老年性骨质疏松的机制
- 批准号:82304806
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ANGPTL4促进血管平滑肌细胞衰老对急性Stanford A型主动脉夹层的作用及其机制
- 批准号:82371582
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 34.96万 - 项目类别:
Bayesian Statistical Learning for Robust and Generalizable Causal Inferences in Alzheimer Disease and Related Disorders Research
贝叶斯统计学习在阿尔茨海默病和相关疾病研究中进行稳健且可推广的因果推论
- 批准号:
10590913 - 财政年份:2023
- 资助金额:
$ 34.96万 - 项目类别:
The predicative values of vascular and metabolic disorders for risk of incident mild cognitive impairment and dementia
血管和代谢紊乱对发生轻度认知障碍和痴呆风险的预测价值
- 批准号:
10661996 - 财政年份:2023
- 资助金额:
$ 34.96万 - 项目类别:
3D force sensing insoles for wearable, AI empowered, high-fidelity gait monitoring
3D 力传感鞋垫,用于可穿戴、人工智能支持的高保真步态监控
- 批准号:
10688715 - 财政年份:2023
- 资助金额:
$ 34.96万 - 项目类别:
CRCNS: Deep Learning to Discover Neurovascular Disruptions in Alzheimer's Disease
CRCNS:深度学习发现阿尔茨海默病的神经血管破坏
- 批准号:
10831259 - 财政年份:2023
- 资助金额:
$ 34.96万 - 项目类别: